Mineralys Therapeutics (NASDAQ: MLYS) files Form 144 to sell 4,584 shares
Rhea-AI Filing Summary
Mineralys Therapeutics (MLYS) filed a Form 144 stating an intended sale of 4,584 shares of common stock in a broker assisted cashless exercise related to an exercise of employee stock options on 06/17/2026. The filing lists prior open-market sales by David Rodman from 03/12/2026 through 06/15/2026 with multiple share quantities and dollar amounts.
Positive
- None.
Negative
- None.
Insights
Notice of intended affiliate sale via Form 144; routine compliance filing.
The filing documents an intended sale of 4,584 shares via a broker assisted cashless exercise on 06/17/2026. Form 144 is a statutory notice required for certain affiliate dispositions; it does not by itself confirm execution.
Prior sales by David Rodman are listed with dates and proceeds through 06/15/2026. Cash‑flow treatment and whether the listed sale executed are not stated in the excerpt; subsequent filings or trade reports would show execution details.